StockData
Radiopharm Theranostics Ltd logo

Radiopharm Theranostics Ltd (RADX) stock

RADXNasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as RDPTF
Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Sep 30, 2026Score 6/30
$0.63−0.04 (-6.33%)

Close on Nov 20, 2026Market cap $7.45MP/E –Yield –

Radiopharm Theranostics gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

For fiscal 2026 it was $263.39K, up 570.6% from the year before.

Annual gross profit

PeriodPeriod endValueChange
FY2026Jun 30, 2026$263.39K+570.6%
FY2025Jun 30, 2025$39.28K-86.9%
FY2024Jun 30, 2024$299.23K+2.3%
FY2023Jun 30, 2023$292.36K–

More Radiopharm Theranostics figures

See a number that looks wrong?